Polymorphonuclear neutrophils (PMNs) are a type of white blood cell crucial to the immune system. Determining the proportion of these cells within a blood sample typically involves differential blood counts performed in hematology laboratories. The process often entails manual microscopic examination of a stained blood smear, where a trained technician identifies and counts different types of white blood cells, including PMNs. Alternatively, automated hematology analyzers can provide a complete blood count, including the percentage of neutrophils. For example, if a differential count of 100 white blood cells reveals that 60 are neutrophils, the percentage of neutrophils, representing the PMN proportion, is 60%. This percentage can be further considered alongside the total white blood cell count to calculate the absolute neutrophil count.
Accurately establishing the relative proportion of PMNs within the bloodstream is vital for diagnosing and monitoring a wide range of medical conditions. Elevated levels may indicate an infection, inflammation, or other physiological stress, while decreased levels can suggest immune deficiencies or bone marrow disorders. Historically, manual blood smear analysis was the only method available, a process that was time-consuming and prone to inter-observer variability. The advent of automated hematology analyzers has significantly improved the speed, accuracy, and standardization of cell counts, contributing to improved patient care and more efficient clinical workflows.
Understanding the method for neutrophil proportion determination provides essential context for interpreting diagnostic results and appreciating the role of these cells in health and disease. Further discussion will delve into specific scenarios where neutrophil counts are particularly informative, the limitations of various counting techniques, and the relationship between neutrophil proportions and overall immune function. Subsequent sections will also explore factors that can influence these counts and their interpretation in a clinical setting.
1. Differential Blood Count
The differential blood count is an integral component in the determination of polymorphonuclear neutrophil (PMN) proportions within a patient’s blood sample. It is through the differential blood count that the percentage of PMNs, relative to other white blood cell types, is established. Without an accurate differential, deriving the PMN percentage becomes impossible. This PMN percentage is then subsequently utilized in conjunction with the total white blood cell count to determine the absolute neutrophil count (ANC), a clinically vital parameter. Consider, for instance, a patient presenting with symptoms suggestive of bacterial infection. A differential blood count revealing an elevated PMN percentage, such as 80%, in the context of a normal or elevated total white blood cell count, strongly supports the diagnosis of a bacterial infection. Without the initial differentiation of cell types, this critical diagnostic information would remain unavailable.
Practical applications of the differential blood count in PMN assessment extend to monitoring the efficacy of treatments targeting inflammatory conditions or infections. Serial differential counts allow clinicians to track changes in the PMN percentage, indicating whether therapeutic interventions are successfully reducing inflammation or controlling an infection. For example, in a patient undergoing treatment for pneumonia, a declining PMN percentage over time, accompanied by a reduction in the total white blood cell count, signifies a positive response to antibiotic therapy. Conversely, a persistently elevated or increasing PMN percentage may indicate treatment failure or the development of antibiotic resistance, prompting adjustments in the treatment regimen. Further, the differential blood count plays a crucial role in identifying neutropenia, a deficiency of neutrophils, which can significantly compromise the patient’s ability to fight off infections. This is particularly relevant in patients undergoing chemotherapy or those with underlying immune deficiencies.
In summary, the differential blood count provides the foundational data essential for establishing PMN proportions and calculating the ANC. Its accuracy directly influences the reliability of clinical interpretations and subsequent medical decisions. Challenges associated with differential counts, such as inter-observer variability in manual methods or limitations in the ability of automated cell counters to accurately differentiate certain cell types, necessitate a thorough understanding of the methodologies and potential sources of error. Linking this knowledge to the broader context of immune function and clinical diagnosis enhances the value of the differential blood count as a diagnostic tool.
2. Automated Cell Counters
Automated cell counters have revolutionized hematology, profoundly impacting the speed, precision, and efficiency of determining polymorphonuclear neutrophil (PMN) counts. These instruments provide a complete blood count (CBC) with differential, rapidly quantifying and classifying various blood cells, including neutrophils, thereby automating a process that was historically manual and labor-intensive. Their accuracy and high-throughput capabilities have made them indispensable tools in modern clinical laboratories.
-
Principle of Operation
Automated cell counters typically employ techniques such as impedance counting, flow cytometry, and light scattering to identify and enumerate blood cells. Impedance counting measures changes in electrical resistance as cells pass through a small aperture, while flow cytometry uses lasers and fluorescent dyes to differentiate cells based on their size, granularity, and surface markers. Light scattering analyzes how cells deflect light, providing information about their size and internal complexity. These sophisticated methods allow for rapid and accurate differentiation of neutrophils from other cell types, crucial for obtaining a reliable PMN count.
-
Accuracy and Precision
Compared to manual microscopy, automated cell counters offer improved accuracy and precision in determining PMN percentages. They eliminate the subjective bias inherent in manual counting, where different technicians may identify and classify cells differently. Furthermore, automated instruments count a much larger number of cells than is practical with manual methods, leading to greater statistical reliability. Quality control measures, including regular calibration and the use of control samples, further ensure the accuracy and consistency of results.
-
Speed and Efficiency
Automated cell counters can process hundreds of samples per hour, significantly reducing the turnaround time for obtaining PMN counts. This speed is particularly critical in emergency situations where rapid diagnosis is essential. The efficiency of automated systems also reduces labor costs and allows laboratory personnel to focus on more complex tasks, such as reviewing abnormal blood smears and performing specialized tests.
-
Limitations and Considerations
Despite their advantages, automated cell counters have limitations. They may misidentify or misclassify cells in certain situations, such as in the presence of abnormal cell morphologies or interfering substances. In such cases, manual review of a blood smear by a trained hematologist is necessary to confirm the automated results and ensure accuracy. Furthermore, automated cell counters require regular maintenance and calibration to maintain optimal performance.
In conclusion, automated cell counters are essential for efficiently and accurately establishing PMN proportions. However, it is critical to understand their limitations and integrate their use with manual review when necessary to ensure reliable clinical decision-making. These instruments provide a rapid and objective assessment of neutrophil counts, aiding in the diagnosis and monitoring of a wide range of conditions.
3. Manual Smear Review
Manual smear review serves as a crucial adjunct to automated cell counting in determining polymorphonuclear neutrophil (PMN) proportions. It offers a level of detail and scrutiny that automated systems, despite their efficiency, cannot always replicate, particularly in cases involving morphological abnormalities or complex cell populations.
-
Confirmation of Automated Results
Manual smear review functions as a confirmatory step for automated cell counts. Discrepancies between the automated results and the clinical picture, or the presence of flags indicating potential abnormalities, necessitate a manual review to ensure accuracy. For example, if an automated count indicates a low PMN percentage but the patient exhibits signs of bacterial infection, a smear review can identify the presence of toxic granulation or Dohle bodies in neutrophils, confirming the suspicion of infection despite the initial automated reading. This confirmation is vital for initiating appropriate treatment.
-
Identification of Morphological Abnormalities
Manual smear review allows for the identification of morphological abnormalities in neutrophils that automated systems might miss. These abnormalities can include toxic granulation, hypersegmentation, atypical nuclear shapes, or the presence of intracellular inclusions. Such findings can provide valuable clues about the underlying cause of changes in PMN numbers. For instance, the presence of hypersegmented neutrophils suggests vitamin B12 or folate deficiency, while toxic granulation indicates severe inflammation or infection. Recognizing these morphological features contributes to a more comprehensive understanding of the patient’s condition.
-
Differentiation of Immature Neutrophils
Manual smear review enables the differentiation of immature neutrophils, such as band neutrophils and metamyelocytes, which may not be accurately classified by automated systems. An increased number of immature neutrophils, known as a left shift, is often indicative of an acute inflammatory response or bone marrow stimulation. This information is crucial for assessing the severity and etiology of the inflammatory process. For example, in cases of severe sepsis, a manual smear review can quantify the proportion of band neutrophils, providing a more accurate assessment of the patient’s immune response than the total PMN count alone.
-
Resolution of Instrument Flags
Automated cell counters often generate flags to alert the operator to potential problems or unusual findings in the sample. Manual smear review is essential for resolving these flags and determining the true PMN proportion. For example, a flag indicating the presence of platelet clumps can interfere with accurate cell counting. By examining the smear manually, a trained technician can differentiate platelet clumps from true neutrophils, ensuring a more accurate assessment of the PMN count. The manual review facilitates correction of the automated count, leading to more appropriate clinical decision-making.
The facets underscore the critical role of manual smear review in refining and validating automated PMN counts. It extends the analysis beyond simple enumeration, providing essential qualitative information about neutrophil morphology and maturation. This detailed assessment allows for more accurate diagnoses, targeted treatment strategies, and a more comprehensive understanding of the patient’s immune status. The integration of manual smear review with automated cell counting maximizes the accuracy and clinical utility of PMN assessment.
4. Absolute Neutrophil Count
The absolute neutrophil count (ANC) is a critical parameter derived from blood tests, directly linked to the process. It quantifies the total number of neutrophils in a microliter of blood, providing a precise measure of the body’s capacity to fight infection. Understanding its derivation is fundamental to interpreting its clinical significance.
-
Calculation Formula
The ANC is not directly measured but calculated using values obtained from a complete blood count (CBC) with differential. The formula is: ANC = (Total White Blood Cell Count) x (% Neutrophils + % Bands). The percentage of neutrophils and bands (immature neutrophils) represents the proportion of neutrophils in the total white blood cell population. This calculation offers a standardized metric for assessing neutrophil levels across different laboratories and patient populations. Example: If a patient has a total white blood cell count of 5,000 cells/L, with 50% neutrophils and 5% bands, the ANC would be 5,000 x (0.50 + 0.05) = 2,750 cells/L.
-
Clinical Significance
The ANC is a primary indicator of the immune system’s ability to defend against bacterial infections. A normal ANC typically ranges from 1,500 to 8,000 cells/L. An ANC below 1,500 cells/L indicates neutropenia, increasing the risk of infection, with the risk escalating as the ANC decreases. Conversely, an elevated ANC, known as neutrophilia, can indicate infection, inflammation, or other conditions such as leukemia. Regular monitoring of the ANC is especially crucial in patients undergoing chemotherapy or other treatments that can suppress bone marrow function and neutrophil production. Fluctuations outside normal ranges necessitate further investigation and potentially therapeutic intervention.
-
Neutropenia Classifications
Neutropenia is categorized based on the severity of the ANC: Mild (1,000-1,500 cells/L), Moderate (500-1,000 cells/L), and Severe (less than 500 cells/L). The risk of infection increases with decreasing ANC levels. Patients with severe neutropenia are at high risk for opportunistic infections and require aggressive prophylactic measures, such as antibiotics or antifungal medications. For instance, a patient with an ANC of 400 cells/L following chemotherapy is at imminent risk of sepsis and requires immediate medical attention and protective isolation.
-
Factors Influencing ANC
Various factors can influence the ANC, including infections, medications, autoimmune diseases, and bone marrow disorders. Infections often lead to a transient increase in the ANC as the body mobilizes neutrophils to fight the invading pathogens. Conversely, certain medications, such as chemotherapy drugs and immunosuppressants, can suppress neutrophil production, leading to a decrease in the ANC. Autoimmune diseases like systemic lupus erythematosus can cause neutropenia through immune-mediated destruction of neutrophils. Bone marrow disorders, such as myelodysplastic syndromes and leukemia, can disrupt normal blood cell production, leading to either increased or decreased ANC levels. Understanding these potential confounding factors is essential for accurate interpretation of the ANC.
Therefore, accurate determination of neutrophil proportions and the subsequent ANC calculation is paramount for assessing immune competence and guiding clinical decision-making. The ANC provides a quantitative and standardized measure that is instrumental in detecting, classifying, and managing a wide range of medical conditions impacting the immune system. Variations in ANC can indicate underlying disorders or the effect of ongoing treatments, underlining the ANC’s significance in clinical practice.
5. Percentage Neutrophils
The percentage of neutrophils, a crucial component of a complete blood count with differential, forms a direct and essential link to the determination of polymorphonuclear neutrophil (PMN) proportion. This metric indicates the relative proportion of neutrophils among all white blood cells, serving as a foundational element in evaluating immune status.
-
Derivation from Differential Counts
The percentage of neutrophils is derived directly from differential white blood cell counts, obtained through either manual microscopic examination of stained blood smears or automated hematology analyzers. The process involves identifying and counting the different types of white blood cells, including neutrophils, lymphocytes, monocytes, eosinophils, and basophils. The neutrophil percentage is then calculated as the number of neutrophils divided by the total number of white blood cells counted, multiplied by 100. For example, if 100 white blood cells are counted and 65 are identified as neutrophils, the neutrophil percentage is 65%. This percentage directly reflects the proportion of PMNs within the overall white blood cell population, a key value in calculating the absolute neutrophil count (ANC).
-
Impact on Absolute Neutrophil Count (ANC)
The percentage of neutrophils plays a pivotal role in calculating the ANC, a more comprehensive measure of neutrophil availability and function. The ANC is calculated by multiplying the total white blood cell count by the percentage of neutrophils (expressed as a decimal). Therefore, any alteration in the percentage of neutrophils directly affects the ANC. A low neutrophil percentage, even with a normal total white blood cell count, can result in a reduced ANC, indicating neutropenia and increased susceptibility to infection. Conversely, a high neutrophil percentage can contribute to an elevated ANC, suggesting an inflammatory response or infection. The ANC provides a more clinically relevant assessment than the percentage alone, as it accounts for both the proportion and total number of neutrophils present.
-
Clinical Interpretation and Significance
The percentage of neutrophils contributes significantly to clinical interpretations of immune function and disease states. An elevated neutrophil percentage often suggests bacterial infection, inflammation, or stress, prompting further investigation to identify the underlying cause. A decreased neutrophil percentage can indicate viral infection, bone marrow suppression, or autoimmune disorders. When considered in conjunction with other clinical findings and laboratory results, the neutrophil percentage aids in differentiating between various diagnostic possibilities and guiding treatment decisions. For example, in a patient presenting with fever and cough, a high neutrophil percentage would support a diagnosis of bacterial pneumonia, while a low neutrophil percentage might suggest a viral respiratory infection.
-
Limitations and Considerations
Despite its importance, the neutrophil percentage has limitations. It provides only a relative measure of neutrophil abundance, not an absolute count. Furthermore, the percentage can be influenced by changes in the numbers of other white blood cell types. For example, a high lymphocyte count can artificially depress the neutrophil percentage, even if the actual number of neutrophils is within the normal range. Therefore, it is crucial to interpret the neutrophil percentage in the context of the total white blood cell count and other relevant laboratory parameters. In situations where precise quantification is essential, the ANC provides a more accurate assessment of neutrophil levels.
In summary, the percentage of neutrophils serves as a fundamental input parameter that directly influences the determination of PMN proportion, which is reflected in the ANC. While informative, the percentage must be interpreted cautiously and in conjunction with other hematologic values to provide a comprehensive assessment of immune status and guide clinical management effectively.
6. Total White Cells
The total white blood cell (WBC) count is an indispensable component when determining the polymorphonuclear neutrophil (PMN) proportion, functioning as a foundational element in the calculation of the absolute neutrophil count (ANC). The total WBC count represents the overall number of leukocytes present in a microliter of blood, providing the denominator against which the percentage of neutrophils is applied. Without an accurate total WBC count, the absolute number of neutrophils cannot be correctly established, rendering an assessment of the patients immune defense capacity unreliable. For example, a patient with a normal percentage of neutrophils (e.g., 60%) might exhibit either a normal or abnormally low ANC if their total WBC count is significantly reduced, highlighting the critical interaction between these two parameters. The total WBC value enables the transformation of a relative percentage into an absolute quantity, thereby revealing the true state of neutrophil availability.
The practical significance of understanding the relationship between the total WBC count and the determination of the PMN proportion manifests in diverse clinical scenarios. In cases of suspected infection, an elevated total WBC count, coupled with an increased percentage of neutrophils, strongly supports a diagnosis of bacterial infection. Conversely, a normal or low total WBC count, despite an elevated percentage of neutrophils, might suggest a compromised bone marrow response or an overwhelming infection depleting the available neutrophil pool. Furthermore, in patients undergoing chemotherapy, the total WBC count serves as a crucial indicator of bone marrow suppression, informing decisions regarding dosage adjustments or the administration of growth factors to stimulate WBC production. These examples illustrate how an informed interpretation of the total WBC count, in conjunction with the PMN proportion, directly influences patient management and treatment strategies.
In summary, the total WBC count is an essential numerical value for establishing the absolute neutrophil count. Its function is to provide the framework to convert the percentage of neutrophils into an absolute number, reflecting the bodys real-time capacity to fight infection. The accurate assessment and interpretation of this value, in tandem with the neutrophil percentage, are crucial for effective diagnosis, monitoring, and treatment across a wide range of medical conditions. Challenges in ensuring accurate WBC counts, such as instrument errors or interfering substances, necessitate rigorous quality control measures and, when necessary, manual review of blood smears to confirm automated results. Ultimately, the precise integration of the total WBC count in the calculation of PMN proportions contributes significantly to informed clinical decision-making.
7. Clinical Interpretation
The process of determining polymorphonuclear neutrophil (PMN) proportion culminates in clinical interpretation, where numerical data transforms into diagnostic insight. An understanding of the numerical PMN parameters, derived from techniques like differential counts and automated cell counters, is inert without an understanding of the clinical context. Clinical interpretation correlates the calculated PMN values, specifically the absolute neutrophil count (ANC) and percentage of neutrophils, with patient presentation, medical history, and other diagnostic findings. A deviation from the normal range, either an elevation or reduction in these values, prompts investigation into potential underlying causes, which can range from acute infections to chronic inflammatory conditions or hematological disorders. The ability to accurately determine PMN proportion is a prerequisite, but the subsequent clinical interpretation provides the actionable information necessary for effective patient management. For example, an elevated ANC in a post-operative patient presenting with fever and localized pain at the surgical site strongly suggests a surgical site infection, guiding the decision to initiate antibiotic therapy. In contrast, an elevated ANC in an otherwise asymptomatic patient might warrant further investigation for underlying myeloproliferative disorders.
Clinical interpretation goes beyond merely identifying abnormal PMN values; it involves discerning patterns and nuances within the data. The rate of change in PMN counts over time, the presence of immature neutrophils (a “left shift”), and the morphological characteristics of neutrophils on blood smears all contribute to a refined clinical assessment. Furthermore, the interpretation must account for factors that can influence PMN counts, such as medications, age, ethnicity, and pregnancy. For instance, corticosteroids can elevate neutrophil counts, while certain ethnic groups may have naturally lower ANC levels. Failing to account for these factors can lead to misdiagnosis or inappropriate treatment decisions. Consider a patient undergoing chemotherapy who develops neutropenia. The degree and duration of neutropenia, coupled with the presence or absence of infection symptoms, determine the need for growth factor support or prophylactic antibiotics. Another example is the differentiation of a leukemoid reaction (a benign increase in WBCs mimicking leukemia) from chronic myelogenous leukemia (CML), which requires careful examination of blood smear morphology and cytogenetic studies, in addition to PMN count analysis.
In summary, clinical interpretation is the critical bridge connecting quantitative hematologic data, including PMN proportion, and informed medical decision-making. Accurate determination of PMN values provides the necessary information, but clinical expertise contextualizes that information, integrating it with the broader clinical picture. Challenges in this process, such as recognizing confounding factors or differentiating between similar conditions, necessitate ongoing education and a thorough understanding of hematology, immunology, and infectious diseases. By effectively integrating the calculation of PMN values with sound clinical judgment, healthcare professionals can optimize patient outcomes and provide targeted, evidence-based care. This ability to determine and interpret PMN proportion is a cornerstone of modern medical practice.
Frequently Asked Questions
The following addresses common inquiries regarding the methods and interpretation of polymorphonuclear neutrophil (PMN) proportion assessment. This information aims to clarify established procedures and highlight critical considerations in clinical practice.
Question 1: What specific blood tests are required to calculate the PMN proportion?
A complete blood count (CBC) with differential is necessary. The differential count enumerates the different types of white blood cells, including neutrophils, providing the percentage of neutrophils which directly represents the PMN proportion within the sample.
Question 2: What is the mathematical formula used in the calculation?
The determination of PMN proportion focuses on the percentage of neutrophils derived from the differential count. The absolute neutrophil count (ANC), a related value, is calculated as: ANC = (Total White Blood Cell Count) x (% Neutrophils + % Bands).
Question 3: How do automated cell counters contribute to PMN calculation?
Automated cell counters provide a rapid and precise method for performing differential blood counts. These instruments identify and enumerate different cell types based on size, granularity, and surface markers, significantly reducing manual labor and potential for human error.
Question 4: When is a manual blood smear review necessary, and what information does it provide?
A manual blood smear review is indicated when automated results are inconsistent with the clinical presentation, or when the instrument flags potential abnormalities. It allows for identification of morphological abnormalities, such as toxic granulation or atypical nuclear shapes, and facilitates accurate differentiation of immature neutrophils, enhancing the precision of PMN assessment.
Question 5: What factors can influence the PMN proportion and potentially lead to inaccurate interpretations?
Several factors can influence PMN proportions, including infections, medications (such as corticosteroids), autoimmune diseases, and bone marrow disorders. Additionally, certain ethnic groups may exhibit variations in normal ranges. Awareness of these factors is critical for accurate clinical interpretation.
Question 6: How does the PMN proportion relate to clinical decision-making in infection management?
The PMN proportion, particularly the ANC, provides critical information for assessing the severity of infection and the patient’s ability to mount an effective immune response. A low ANC indicates neutropenia, increasing the risk of infection and potentially requiring prophylactic measures. Conversely, an elevated ANC may suggest an ongoing infection or inflammatory process, guiding treatment decisions.
This overview provides foundational knowledge for understanding the determination of PMN proportion. Accuracy in technique and awareness of influencing factors are paramount for translating numerical data into clinically relevant insights.
The succeeding discussion will delve into specific clinical scenarios where PMN values are particularly informative, emphasizing the integration of laboratory results with patient-specific clinical information.
Guidance on PMN Proportion Assessment
The following guidance aims to provide strategies for optimizing the process, focusing on precision, contextual awareness, and diligent validation. Implementation of these points may contribute to enhanced accuracy and reliability in the determination of polymorphonuclear neutrophil (PMN) proportions.
Tip 1: Employ Rigorous Quality Control Measures: Implement and maintain a comprehensive quality control program for hematology analyzers. Regular calibration and the use of control samples are essential for ensuring accurate and consistent results. Failure to adhere to stringent QC protocols may compromise the reliability of PMN counts.
Tip 2: Validate Automated Results with Manual Smear Reviews: Consistently validate automated cell counter results with manual blood smear reviews, especially when flags are triggered or when clinical findings are inconsistent with automated data. The ability to identify morphological abnormalities through manual review is critical for accurate assessment.
Tip 3: Account for Medication Effects: Consider the potential influence of medications on PMN counts. Corticosteroids, for instance, can artificially elevate neutrophil counts. Thorough patient history review is necessary to interpret PMN values accurately.
Tip 4: Differentiate Immature Neutrophils Accurately: Ensure precise differentiation of immature neutrophils (bands) from mature neutrophils. An elevated band count (a “left shift”) indicates acute inflammation or bone marrow stimulation and requires careful consideration.
Tip 5: Interpret in Conjunction with Total White Blood Cell Count: Interpret the neutrophil percentage in the context of the total white blood cell count. A high neutrophil percentage without an elevated total WBC count may suggest a compromised bone marrow response.
Tip 6: Recognize Ethnic Variations in Normal Ranges: Be cognizant of ethnic variations in normal neutrophil ranges. Some ethnic groups may naturally exhibit lower absolute neutrophil counts, which should be considered when interpreting results.
Tip 7: Monitor Trends in PMN Counts Over Time: Assess trends in PMN counts over time, rather than relying solely on single data points. Serial measurements can provide valuable insight into disease progression or treatment response.
Adherence to these recommendations promotes optimized PMN evaluation, contributing to accurate diagnoses and effective patient care. Consistent attention to detail throughout the process is vital for dependable results.
The subsequent section will address limitations of existing methodologies while providing insights on future considerations.
Conclusion
This exposition has detailed the methodologies employed to determine polymorphonuclear neutrophil (PMN) proportion, emphasizing the interplay between manual techniques, automated analysis, and informed clinical interpretation. Accurate quantification of PMNs necessitates a thorough understanding of differential blood counts, the capabilities and limitations of automated cell counters, and the critical role of manual blood smear review. The process involves deriving the neutrophil percentage from the differential count and applying it to the total white blood cell count to obtain the absolute neutrophil count (ANC), a crucial indicator of immune competence. Furthermore, careful consideration must be given to factors that can influence PMN counts, such as medications, infections, and ethnic variations.
The continued refinement of techniques for accurately assessing PMN proportions remains a vital area of focus. The future of PMN assessment will likely involve more sophisticated automation, improved algorithms for cell identification, and integration with other diagnostic modalities. Given the significance of PMNs in immune defense and the diagnosis of a wide range of medical conditions, ongoing efforts to enhance the precision and reliability of PMN assessment are essential for improving patient outcomes and advancing medical knowledge.
